Buy or sell Genapsys stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Genapsys Stock

DNA Sequencing Technology

Founded

2010

Notable Investors

Oxford Finance Corporation

Headquarters

Redwood City CA, US

Total Funding

$202M

About Genapsys Stock

GenapSys is a sequencing technology company that aims to help support the control and limit the spread of current and future outbreaks. The company's main goal is to transform research and diagnostics with an affordable, scalable genomic sequencing ecosystem.

In July 2022, Genapsys filed for Chapter 11 bankruptcy.

GenapSys was founded in 2010 and is headquartered in Redwood City, California. Notable investors include Decheng Capital, Oxford Finance Corporation, and Farallon Capital Management. 

Investors

Funding History

March 2013$8.5M
November 2013$36.5M
December 2017$86.2M
February 2021$70.6M

Management

Chief Executive Officer

Jason Myers

Chief Financial Officer

Britton Russell

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 290K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo